You’re using a public version of DrugPatentWatch with 5 free searches available | Register to unlock more free searches. CREATE FREE ACCOUNT

Last Updated: March 29, 2024

Claims for Patent: 5,449,607


✉ Email this page to a colleague

« Back to Dashboard


Summary for Patent: 5,449,607
Title: Assay for the quantitative determination of substrates capable of undergoing enzymatic hydrolysis to release long-chain fatty acids
Abstract:A method of quantitative assay for a substrate such as triglyceride capable of undergoing enzymatic hydrolysis to release long chain fatty acids in an albumin-containing clinical sample comprises incubating the albumin-containing clinical sample with an enzyme such as lipase which acts upon the substrate to be assayed under conditions effective to release fatty acid therefrom, causing the fatty acid thus released to bind to a fatty acid binding protein (FABP) and assaying the binding of the fatty acid to the FABP.
Inventor(s): Wilton; David C. (Bassett, GB2)
Assignee: British Technology Group Limited (London, GB2)
Application Number:08/107,702
Patent Claims:1. A method for assaying a substrate present in an albumin-containing clinical sample which substrate can be enzymatically hydrolyzed to release long chain fatty acids therefrom, said method comprising the steps of:

(i) adding to said clinical sample an enzyme which releases fatty acids from said substrate, to form an incubation mixture;

(ii) incubating said incubation mixture;

(iii) adding to said incubation mixture before, during or after step (ii) fatty acid binding protein (FABP); and

(iv) measuring binding of said released fatty acids to said FABP.

2. The method according to claim 1 wherein the FABP is measuring by a method in which a competitive probe which binds to the FABP in competition with the released fatty acids is allowed to interact with the FABP and the free or bound competitive probe is then measuring directly or indirectly.

3. The method according to claim 2 wherein the probe is measuring by fluorescence displacement.

4. The method according to claim 3 wherein the probe is an anion of 11-(dansylamino)undecanoic acid.

5. The method according to claim 2 wherein the probe is measuring colorimetrically.

6. The method according to claim 5 wherein the probe is hemin.

7. The method according to claim 1 for assaying triglycerides wherein the enzyme is lipase.

8. The method according to claim 1 wherein the FABP is hepatic.

9. The method according to claim 1 wherein the clinical sample is a serum sample.

10. The method according to claim 1 wherein the clinical sample is 0.1 to 1 .mu.l.

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.